| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥332.4B | ¥337.2B | -1.4% |
| Operating Income | ¥-14.1B | ¥3.5B | -29.9% |
| Ordinary Income | ¥-8.3B | ¥3.9B | -9.8% |
| Net Income | ¥-13.5B | ¥2.3B | -689.5% |
| ROE | -3.5% | 0.5% | - |
FY2026 Q3 results: Revenue of ¥332.4B (YoY -1.4%), Operating Loss of ¥14.1B (versus ¥3.5B profit prior year), Ordinary Loss of ¥8.3B (YoY -9.8B), and Net Loss of ¥13.5B (YoY -15.8B, -689.5%). The company swung from modest profitability to substantial losses across all profit levels, marking a significant deterioration in operating performance. Revenue remained nearly flat while profitability collapsed, driven by negative operating leverage as SG&A expenses of ¥97.8B exceeded gross profit of ¥83.8B. The negative operating margin of -4.2% represents a deterioration of 14.5 percentage points from the prior year's +10.3% margin.
Revenue declined 1.4% YoY to ¥332.4B, with regional performance mixed. The Americas region grew 7.6% to ¥142.9B while Asia declined 2.8% to ¥170.2B and Japan decreased 11.1% to ¥98.3B in external sales. Despite relatively stable topline, profitability collapsed due to structural operating expense issues. Gross profit of ¥83.8B represented a 25.2% margin, down from prior periods, but the critical driver of operating losses was SG&A expenses of ¥97.8B consuming 29.4% of revenue, creating a negative operating leverage where fixed costs exceeded gross profit generation. Cost of sales increased to ¥248.6B, representing 74.8% of revenue.
At the operating level, losses of ¥14.1B contrasted sharply with ¥3.5B profit in the prior year, a swing of ¥17.6B. Non-operating items provided partial relief with net non-operating income of ¥5.8B, primarily driven by foreign exchange gains of ¥5.6B, dividend income of ¥1.0B, and interest income of ¥0.6B, offset by interest expenses of ¥2.0B and commission fees of ¥2.0B. The company also recorded extraordinary income of ¥2.3B from investment securities sales. However, these non-operating and extraordinary gains were insufficient to offset operating weakness, resulting in an ordinary loss of ¥8.3B and pretax loss of ¥8.3B.
Income tax expense of ¥5.2B was recorded despite pretax losses, indicating tax adjustments or non-deductible items that further depressed net income to a loss of ¥13.5B. Basic EPS deteriorated to ¥-70.18 from ¥11.96 prior year. This represents a "revenue flat, profit down" pattern driven by operational inefficiency and cost structure misalignment rather than demand collapse.
Japan segment generated revenue of ¥244.9B with operating loss of ¥11.8B (margin -4.8%), representing the core business by revenue share but showing severe profitability pressure. The Americas region contributed revenue of ¥142.9B with operating loss of ¥3.9B (margin -2.8%), while Asia recorded revenue of ¥170.2B with operating income of ¥0.6B (margin +0.4%), the only profitable segment. Japan's operating loss of ¥11.8B deteriorated significantly from ¥1.9B profit in the prior year, indicating domestic market challenges including demand weakness and cost pressures. The Americas loss widened from ¥4.2B to ¥3.9B, showing marginal improvement. Asia's profit declined from ¥3.0B to ¥0.6B, suggesting margin compression across all regions. Inter-segment eliminations contributed positive ¥0.1B adjustment. The concentration of losses in the Japan segment, which represents the largest revenue base, highlights structural domestic profitability challenges requiring urgent operational restructuring.
[Profitability] ROE of -3.5% deteriorated sharply from positive levels in prior periods, reflecting the net loss. Operating margin of -4.2% represents a 14.5 percentage point deterioration from approximately +10.3% in the prior year. Net profit margin of -4.1% versus prior positive margins demonstrates the severity of profitability collapse. Gross margin of 25.2% declined from higher historical levels while SG&A ratio of 29.4% created negative operating leverage. Interest coverage turned deeply negative at -7.11x, indicating operating income insufficient to cover interest expenses of ¥2.0B. [Cash Quality] Cash and deposits increased to ¥90.9B from ¥67.5B YoY (+34.7%), providing ¥0.46 coverage of short-term debt of ¥196.3B, which remains below the prudent threshold of 1.0x and signals potential liquidity stress. [Investment Efficiency] Asset turnover of 0.394x declined from prior periods and falls below industry median of 0.56x, indicating inefficient asset utilization. Inventory of ¥210.2B represents 24.9% of total assets, with inventory turnover of approximately 308 days substantially exceeding industry median of 112 days, highlighting severe working capital inefficiency. [Financial Health] Equity ratio of 46.3% compares to 48.4% prior year, remaining within acceptable range but below industry median of 63.8%. Current ratio of 173.4% and quick ratio of 110.2% appear adequate, but are distorted by elevated inventory levels. Debt-to-equity ratio of 1.16x increased from prior levels, with total interest-bearing debt of ¥285.7B. The company maintains ¥196.3B in short-term borrowings representing 68.7% of total liabilities, creating refinancing risk. Working capital of ¥244.2B is heavily tied up in inventory, constraining operational flexibility.
Cash and deposits increased ¥23.4B YoY to ¥90.9B despite operating losses, indicating cash sources outside operations. The increase appears driven by investment securities sales generating ¥2.3B in gains and potentially increased borrowing, as short-term loans rose significantly. With operating losses of ¥14.1B and net losses of ¥13.5B, operating cash generation was likely negative before working capital changes. Inventory increased ¥31.6B YoY to ¥210.2B, representing a substantial cash outflow and working capital deterioration. Trade receivables of ¥70.5B remained relatively stable while trade payables of ¥63.8B increased modestly, suggesting limited payables management benefit. Investment securities increased ¥18.6B to ¥40.4B, representing significant investing outflow or valuation gains. The cash position of ¥90.9B provides only 0.46x coverage of short-term debt of ¥196.3B, indicating dependence on refinancing or asset liquidation. The combination of operating losses, inventory buildup, and investment securities increases suggests cash consumption partially offset by borrowing increases and securities sales. Liquidity management warrants close monitoring given the mismatch between operating cash generation and short-term obligations.
Ordinary loss of ¥8.3B versus operating loss of ¥14.1B shows net non-operating contribution of approximately ¥5.8B, representing significant reliance on non-operating items to partially offset operational weakness. Non-operating income of ¥9.9B comprised primarily foreign exchange gains of ¥5.6B (56% of non-operating income), dividend income of ¥1.0B, and interest income of ¥0.6B. The FX gain of ¥5.6B is inherently volatile and non-recurring in nature, flattering the ordinary loss relative to core operations. Non-operating income represents 3.0% of revenue, while non-operating expenses of ¥4.1B include interest expense of ¥2.0B and commission fees of ¥2.0B. The ¥5.6B FX gain contrasts with ¥1.1B in FX losses also recorded, suggesting mixed currency exposure outcomes. Extraordinary income of ¥2.3B from investment securities sales further supplements reported losses but represents one-time asset monetization rather than sustainable earnings. The company recorded income tax expense of ¥5.2B despite pretax losses, yielding an effective tax rate exceeding 100%, which indicates tax adjustments, deferred tax impacts, or non-deductible expenses that degrade cash tax efficiency. Operating cash flow data is unavailable for direct comparison to net income, but the combination of operating losses, inventory accumulation of ¥210.2B, and working capital tied up in 308 days of inventory turnover suggests negative operating cash flow and poor earnings quality. The heavy dependence on non-recurring FX gains and securities sales to partially offset core operating losses indicates unsustainable earnings composition requiring urgent operational correction.
Full-year guidance calls for revenue of ¥442.0B (YoY -6.9%), operating income of ¥10.0B (YoY +126.2%), ordinary income of ¥9.0B (YoY +162.3%), and net income of ¥5.5B with EPS of ¥28.59. Q3 cumulative revenue of ¥332.4B represents 75.2% progress versus full-year target, slightly above the standard 75% benchmark for Q3. However, operating loss of ¥14.1B versus ¥10.0B full-year profit target implies Q4 operating income must reach ¥24.1B to achieve guidance, representing an unprecedented quarterly turnaround. Similarly, ordinary loss of ¥8.3B implies Q4 ordinary income of ¥17.3B required, and net loss of ¥13.5B implies Q4 net income of ¥19.0B needed. The guidance implies dramatic Q4 improvement across all profit metrics, requiring operating margin expansion to approximately 21.9% in Q4 from -4.2% in Q3 cumulative. No forecast revision was announced this quarter, suggesting management maintains confidence in Q4 recovery driven by seasonal factors, cost reductions, or inventory conversion. The aggressive Q4 assumptions carry high execution risk given the structural cost issues and working capital constraints evident in Q3 results. Achievement depends critically on SG&A reduction, gross margin recovery, inventory liquidation, and potential non-recurring gains, with limited visibility on specific initiatives disclosed.
Annual dividend forecast of ¥21.00 per share is maintained, consisting of interim and year-end payments. Based on net loss of ¥13.5B and forecasted net income of ¥5.5B for the full year, the implied payout ratio would be approximately 141% against full-year forecast EPS of ¥28.59 (¥21.00/¥28.59), indicating dividend payments exceeding forecasted earnings. Q3 cumulative payout ratio is negative at -57.8% given the net loss, meaning dividends are being paid from retained earnings or cash reserves rather than current earnings. No share buyback program is disclosed. The total return ratio cannot be calculated due to lack of share repurchase data, but dividend-only payout exceeding 100% of forecasted earnings raises sustainability concerns. Cash and deposits of ¥90.9B provide dividend payment capacity in the near term, but continued losses would erode cash reserves and equity base. The equity base declined ¥27.9B to ¥391.1B, reflecting net loss and comprehensive loss impacts. Dividend sustainability depends on achieving full-year guidance and restoring positive operating cash flow, with current loss trajectory creating pressure to reassess dividend policy if Q4 recovery fails to materialize.
Operating loss persistence risk: SG&A expenses of ¥97.8B exceeded gross profit of ¥83.8B by ¥14.0B in Q3, creating structural negative operating leverage. Unless management reduces fixed costs by at least 15% or improves gross margin by 4+ percentage points, operating profitability cannot be restored, threatening full-year guidance and requiring potential restructuring.
Inventory and working capital risk: Inventory of ¥210.2B represents 308 days of turnover, nearly triple the industry median of 112 days, indicating substantial obsolescence risk and cash consumption. Working capital of ¥244.2B ties up 29% of assets, constraining liquidity and requiring potential inventory writedowns of ¥20-40B if market conditions deteriorate or products become obsolete.
Refinancing and liquidity risk: Short-term borrowings of ¥196.3B exceed cash of ¥90.9B by ¥105.4B, with cash coverage ratio of 0.46x below prudent levels. Debt maturities concentrated in short-term create refinancing risk if operating losses continue and banks tighten credit terms, potentially requiring asset sales or equity raises at unfavorable terms to meet obligations.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE of -3.5% substantially underperforms the industry median of 5.8% and places the company in the bottom quartile. Operating margin of -4.2% compares unfavorably to industry median of 8.9%, representing a gap of 13.1 percentage points. Net profit margin of -4.1% versus industry median of 6.5% indicates severe profitability underperformance requiring operational restructuring.
Financial Health: Equity ratio of 46.3% falls below the industry median of 63.8%, indicating higher leverage and lower financial flexibility. Current ratio of 173.4% appears adequate but is distorted by elevated inventory; industry median of 2.87x suggests comparable liquidity positioning. Debt positioning is weaker with financial leverage of 2.16x above industry median of 1.53x.
Efficiency: Asset turnover of 0.394x significantly underperforms industry median of 0.56x, indicating inefficient asset utilization. Inventory turnover of 308 days is nearly triple the industry median of 112 days, representing severe working capital inefficiency. Operating working capital turnover cannot be directly compared but the company's elevated inventory and receivables days suggest bottom-quartile operational efficiency.
Return Metrics: ROA of -3.4% compares unfavorably to industry median of 3.4%, a gap of 6.8 percentage points driven by both negative margins and weak asset turnover. The company's negative returns place it in the bottom decile of manufacturing peers, requiring urgent margin restoration to reach industry norms.
※ Industry: Manufacturing (105 companies), Comparison: FY2025 Q3 period, Source: Proprietary analysis
Operating structure requires urgent restructuring: The fundamental mismatch where SG&A expenses of ¥97.8B (29.4% of revenue) exceed gross profit of ¥83.8B (25.2% margin) by ¥14.0B creates structural losses independent of revenue levels. Management must reduce fixed cost base by minimum 15% or approximately ¥15B annually, or improve gross margin to 30%+ through pricing power or cost reduction, to restore breakeven operations. The Japan segment's ¥11.8B operating loss despite ¥244.9B revenue indicates domestic operations averaging -4.8% margins require either turnaround or rationalization.
Inventory and working capital conversion critical for liquidity: Inventory of ¥210.2B turning at 308 days versus industry median 112 days represents approximately ¥130B in excess inventory at normalized turnover levels. Reducing inventory to industry norms could release ¥100-130B in cash over 12-18 months, substantially improving liquidity metrics and reducing dependence on short-term borrowings of ¥196.3B. Current cash coverage of 0.46x for short-term debt creates refinancing pressure requiring either accelerated inventory liquidation, asset sales of investment securities (¥40.4B), or covenant renegotiation.
Full-year guidance achievement requires unprecedented Q4 performance: Guidance implies Q4 operating income of ¥24.1B versus ¥14.1B cumulative loss, demanding 21.9% Q4 operating margin compared to -4.2% Q3 rate. This necessitates either substantial one-time gains, seasonal revenue spike with dramatically improved mix, or cost actions not yet evident. Investors should monitor monthly sales trends, inventory levels, and any announced restructuring to assess guidance feasibility, with high probability of downward revision if Q4 improvement absent by January 2026.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.